Image
Accomplishments
Burkina Faso has stopped mass drug administration (MDA) for lymphatic filariasis in 89% of endemic districts in the country following the likely interruption of transmission of the causative parasite in 62 districts as of FY21 (October 2020 – September 2021). Prevalence of infection has been reduced significantly in the remaining eight districts due to ongoing MDA.
All trachoma endemic health districts have reached the elimination threshold of trachomatous inflammation—follicular (TF) of less than 5% among children ages 1-9 and have stopped MDA as of FY18 (October 2017 – September 2018).
Two rounds of onchocerciasis MDA implemented each year for the past four years resulted in 80% epidemiological coverage in FY22 (October 2021 – September 2022).
Burkina Faso has implemented MDA against SCH/STH since 2004. After successfully reducing STH prevalence through MDA, the WHO recommended stopping STH MDA throughout the country in 2021. Burkina Faso continues to provide deworming treatment to children under 5 and pregnant women. As a result of eight to nine rounds of high coverage MDA, Burkina Faso will conduct a schistosomiasis (and soil-transmitted helminthiasis) impact assessment in 20 districts in 2023.
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021
LYMPHATIC FILARIASIS
of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))
of ever-endemic districts in post-surveillance phase as of FY21
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
of persons no longer at risk as of FY21 among those who were ever at risk
TRACHOMA
of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))
of ever-endemic districts in post-MDA surveillance phase as of FY21
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))*
*Burkina Faso conducted TSS in 36 HDs by the end of FY21 with results pending in one additional district.
of persons no longer at risk as of FY21 among those who were ever at risk
Onchoceriasis
of ever endemic districts have been treated at least once as of FY21
(in cases where a country has more treated districts reported than, ever endemic, the adjusted percent is 100%)
Schistosomiasis
of ever endemic districts have been treated at least once as of FY21
SOIL-TRANSMITTED Helminthiasis
